Sign up to save your podcasts
Or
Share Treating TAVR Patients During The COVID - 19 Era
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Treating TAVR Patients During The COVID - 19 Era
In this episode, Boston Scientific’s own Global Chief Medical Officer Ian Meredith sits down with Doctors Molly Szerlip and Vinod Thourani to discuss treating TAVR patients during the COVID-19 era.
Chapter 1: Treating TAVR Patients Today (0:46)
Chapter 2: Adapting TAVR Practices to Ensure Patient Safety (8:27)
Chapter 3: Patient and Procedural Strategy (14:55)
Chapter 4: The Heart Team in a Virtual World (22:45)
Chapter 5: The Impact on Clinical Trial Research (26:08)
View all episodes
By Boston Scientific
4
1212 ratings
In this episode, Boston Scientific’s own Global Chief Medical Officer Ian Meredith sits down with Doctors Molly Szerlip and Vinod Thourani to discuss treating TAVR patients during the COVID-19 era.
Chapter 1: Treating TAVR Patients Today (0:46)
Chapter 2: Adapting TAVR Practices to Ensure Patient Safety (8:27)
Chapter 3: Patient and Procedural Strategy (14:55)
Chapter 4: The Heart Team in a Virtual World (22:45)
Chapter 5: The Impact on Clinical Trial Research (26:08)